Lexaria Bioscience (LEXX) Revenue (2017 - 2026)
Lexaria Bioscience (LEXX) recorded Revenue of $20,000 in fiscal Q2 2026 (quarter ended Feb 28, 2026), down 88.5% from $174,000 a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Revenue (2017 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported Revenue of $705,923, up 52.0% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
- Across earlier fiscal years, Revenue came in at $464,278 in FY2024 (+105.2%), $226,208 in FY2023 (-11.4%), $255,397 in FY2022 (-64.7%) and $722,738 in FY2021 (+129.6%).
- The fiscal Q2 2026 figure is the lowest quarterly Revenue since fiscal Q1 2022.
- On a year-over-year basis, Revenue rose in six of the last seven quarters, with growth averaging 49.8%.
- Peak year-over-year performance for Revenue in the last five years was growth of 624.1% in fiscal Q2 2024, against a decline of 95.3% in fiscal Q1 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Lexaria Bioscience | 3.30 Mn | -12.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 20,000.00 |
| Aug 31, 2025 | 174,000.00 |
| May 31, 2025 | 174,000.00 |
| Feb 28, 2025 | 174,000.00 |
| Nov 30, 2024 | 183,923.00 |
| Aug 31, 2024 | 84,000.00 |
| May 31, 2024 | 84,000.00 |
| Feb 29, 2024 | 145,000.00 |
| Nov 30, 2023 | 151,278.00 |
| Aug 31, 2023 | 30,741.00 |
| May 31, 2023 | 77,707.00 |
| Feb 28, 2023 | 20,025.00 |
| Nov 30, 2022 | 97,735.00 |
| Aug 31, 2022 | 111,150.00 |
| May 31, 2022 | 99,717.00 |
| Feb 28, 2022 | 30,650.00 |
| Nov 30, 2021 | 13,880.00 |
| Aug 31, 2021 | 31,021.00 |
| May 31, 2021 | 204,055.00 |
| Feb 28, 2021 | 192,006.00 |
API Access
Lexaria Bioscience Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();